Regular Glucosamine Use Linked to Fewer Chronic Diseases

by September 10, 2025

Comments Off on Regular Glucosamine Use Linked to Fewer Chronic Diseases

A Comprehensive Overview

Glucosamine has emerged as a prominent supplement associated with various health benefits, particularly in relation to non-communicable chronic diseases. According to a recent analysis of UK Biobank data, regular glucosamine use was notably linked to a reduction in the incidence of several chronic diseases. The specific conditions affected included:

• Esophageal cancer
• Gout
• Chronic obstructive pulmonary disease (COPD)
• Colorectal cancer
• Chronic liver disease
• Heart failure
• Coronary heart disease

It is crucial to note that while significant associations were observed, this study is observational and does not establish direct causality.

Understanding Glucosamine

Glucosamine is defined as a sugar molecule with an amine group (an amino sugar), commonly utilized as a dietary supplement. It is widely taken by approximately 20% of middle-aged adults across regions including the U.S., U.K., and Australia. The supplement is often prescribed to alleviate knee pain in osteoarthritis patients [3].

Studies have indicated that glucosamine may also yield beneficial effects on:

• Inflammatory responses [4]
• Reducing risks of cardiovascular disease
• Minimizing risks associated with type 2 diabetes
• Lower lung cancer risks
• Reducing all-cause mortality rates [7]

The Study Cohort

The study analyzed a substantial dataset from the population-centered UK Biobank, involving 269,033 participants, of whom 52,556 (or 19.5%) were regular users of glucosamine. This cohort is notable as it represents one of the largest datasets for this research question.

Participants reported their glucosamine use via self-administered questionnaires that simplified responses to a binary format (‘yes’ or ‘no’). Unfortunately, this format prevented further examination of crucial details, such as dose-response relationships or the forms of glucosamine used, including glucosamine sulfate, glucosamine hydrochloride, and N-acetyl-glucosamine.

Assessing Disease Risk

The data analysis, which included adjustments for potential confounding variables, revealed that regular glucosamine use correlated with a significantly lower risk for the aforementioned chronic diseases. Given the robustness of these associations, researchers took extensive measures to account for variables such as age and gender through propensity score matching (PSM).

Associations Found

Potential Mechanisms

The researchers speculated on several biological mechanisms that could underlie the observed relationships between glucosamine use and reduced disease risk. Some suggested mechanisms include:

• Mitigation of atherosclerotic lesions
• Anti-inflammatory effects
• Mimicking metabolic effects akin to a low-carbohydrate diet
• Antioxidant properties
• Modulation of various cellular processes

Limitations of the Study

While the UK Biobank's extensive dataset provides valuable insights, there are limitations:

• The reasons for glucosamine intake remain unclear, which could skew the results if participants taken for joint discomfort were classified differently.
• The study population disproportionately represents individuals of European ethnic backgrounds with generally healthier habits.
• Potential bias from conscious health awareness among glucosamine users was also noted.

Conclusion and Future Directions

Glucosamine emerges as a promising, low-cost option for preventing chronic diseases, expanding its benefits beyond joint health. Nevertheless, because of its observational nature, establishing causation remains vital. Additional studies should focus on elucidating the molecular processes involved in the associations observed.

In summary, the findings present glucosamine as a possible preventive agent for age-related chronic diseases, supported by robust data, yet further research is essential to validate these associations.

Literature

[1] He, J., et al. (2025). Regular glucosamine supplementation and risk of age-related chronic diseases: evidence from a propensity score-matched cohort study. Aging Clinical and Experimental Research, 37(1), 259.

[2] Ma, H., et al. (2020). Glucosamine Use, Inflammation, and Genetic Susceptibility, and Incidence of Type 2 Diabetes: A Prospective Study in UK Biobank. Diabetes Care, 43(4), 719–725.

[3] Vo, N. X., et al. (2023). Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review. Pharmacy (Basel), 11(4), 117.

[4] Dalirfardouei, R., et al. (2016). Molecular mechanisms and biomedical applications of glucosamine as a potential multifunctional therapeutic agent. Life Sciences, 152, 21–29.

[5] Ma, H., et al. (2019). Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. BMJ (Clinical Research Ed.), 365, l1628.

[6] Li, G., et al. (2022). Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study. The European Respiratory Journal, 59(3), 2101399.

[7] Li, Z. H., et al. (2020). Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study. Annals of the Rheumatic Diseases, 79(6), 829–836.